Today's Peptide Chemists Face A Dizzying Array Of Synthesizer Choices

Times have certainly changed since the first automated peptide synthesizer hit the market in the mid-1980s. Early machines were capable of processing one peptide at a time, a major improvement over manually adding reagents, washing between reactions, and moving on to the next step. You just set up the synthesizer, and in the morning there was your peptide. Nowadays, the choices are growing, as more manufacturers offer instruments for large-scale preparation or for multiple, simultaneous prepara

| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Moreover, there is now one instrument on the market, with the possibility of others to come, that allows control of reaction temperature and atmosphere. Such instruments are intended as general-purpose organic synthesizers capable of stringing together a variety of reactants, not only for peptide synthesis but also for oligonucleotide synthesis or for use in combinatorial chemistry, in which complex multifunctional molecules are built up from a pantheon of monomers.

The array of choices in peptide synthesizers is almost dizzying, especially when one considers that only about 1,000 automated synthesizers are currently installed and about 200 to 300 are sold each year, according to industry sources. Industry insiders report that today there are five major manufacturers of peptide synthesizers in terms of sales, with an aggregate of 10 individual units on the market and two more soon to be released. Each product is intended for a different type of user. They ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Scott Veggeberg

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours